Lagnason, Quinn Ryzle R.

HRN: 21-39-75  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2025
OXACILLIN 500MG (VIAL)
08/24/2025
08/31/2025
IV
450mg
Q6H
Cellulitis
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines